Peter Fickert
Elite in Sclerosing Cholangitis

Peter Fickert

Graz, AT 
Elite in Sclerosing Cholangitis
Graz, AT 
OverviewLocationsClinical Research

Overview

Peter Fickert practices in Graz, Austria. Mr. Fickert is rated as an Elite expert by MediFind in the treatment of Sclerosing Cholangitis. His top areas of expertise are Cholestasis, Sclerosing Cholangitis, Cholangitis, Thrombectomy, and Liver Transplant.

His clinical research consists of co-authoring 117 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 25 articles in the study of Sclerosing Cholangitis.

Gender
Male

Locations

Graz, 8036, Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 2, Double-Blind, Randomized, Parallel Group Study Evaluating the Efficacy, Safety, and Tolerability of Obeticholic Acid Administered in Combination With Bezafibrate in Subjects With Primary Biliary Cholangitis Who Had an Inadequate Response or Who Were Unable to Tolerate Ursodeoxycholic Acid
A Phase 2, Double-Blind, Randomized, Parallel Group Study Evaluating the Efficacy, Safety, and Tolerability of Obeticholic Acid Administered in Combination With Bezafibrate in Subjects With Primary Biliary Cholangitis Who Had an Inadequate Response or Who Were Unable to Tolerate Ursodeoxycholic Acid
Enrollment Status: Active_not_recruiting
Publish Date: September 29, 2025
Intervention Type: Drug
Study Drugs: Obeticholic Acid, Bezafibrate
Study Phase: Phase 2

117 Total Publications

FXR adapts hepatic mitochondrial function to increased substrate oxidation in patients with obesity.
FXR adapts hepatic mitochondrial function to increased substrate oxidation in patients with obesity.
Journal: Science translational medicine
Published: August 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Fickert's expertise for a condition
ConditionClose
View All 29 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile